Skip to content

Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00689871
Enrollment
715
Registered
2008-06-04
Start date
1999-01-31
Completion date
2011-08-31
Last updated
2014-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Augmentation, Breast Reconstruction, Revision of Augmentation or Reconstruction

Brief summary

Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary augmentation, primary reconstruction, or revision of existing breast implants.

Interventions

Sponsors

Allergan Medical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female, age 18 years or older * Seeking primary breast augmentation (i.e., no previous breast implant surgery) indicated for the following: patient dissatisfaction with size or shape of breast (e.g., mammary hypoplasia, asymmetry, ptosis, or aplasia * Seeking primary breast reconstruction * Seeking breast revision-augmentation * Seeking breast revision-reconstruction * Adequate tissue available to cover implants * Patients at MRI designated sites must be willing to undergo MRI at their 1,3, 5, 7 and 9-year follow-up visits (serial MRI). The patient must be eligible for MRI (for example, no implanted metal or metal devices and no history of severe claustrophobia that may make her ineligible for MRI).

Exclusion criteria

* Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy * Existing carcinoma of the breast, without mastectomy * Abscess or infection in the body at the time of enrollment * Pregnant or nursing * Have any disease, including uncontrolled diabetes (e.g., HbAIc \> 8%), that is clinically known to impact wound healing ability * Show tissue characteristics that are clinically incompatible with mammaplasty, such as tissue damage resulting from radiation, inadequate tissue, compromised vascularity or ulceration * Have, or under treatment for, any condition that may constitute an unwarranted surgical risk (e.g., unstable cardiac or pulmonary problems) * Show psychological characteristics that may be incompatible with the surgical procedure and the prosthesis, such as inappropriate attitude or motivation (e.g., body dysmorphic disorder) * Are not willing to undergo further surgery for revision, if medically required

Design outcomes

Primary

MeasureTime frameDescription
Local Complications10 yearsBy patient risk of complications occuring in at least 5% of patients in 1 or more cohorts

Secondary

MeasureTime frameDescription
Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale10 yearsSatisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied

Countries

United States

Participant flow

Recruitment details

Enrollment: January 6, 1999-June 30, 2000 at multiple US sites

Participants by arm

ArmCount
Primary Augmentation
All women implanted for an indication of primary breast augmentation
455
Primary Reconstruction
All women implanted for an indication of primary breast reconstruction
98
Revision-augmentation
All women implanted for revision of a breast augmentation
147
Revision-reconstruction
All women implanted for revision of a breast reconstruction
15
Total715

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyDeath11022
Overall StudyExplanted of All Study Devices3625293
Overall StudyLost to Follow-up12313371
Overall StudyPhysician Decision2110
Overall StudyWithdrawal by Subject13341

Baseline characteristics

CharacteristicPrimary AugmentationPrimary ReconstructionRevision-augmentationRevision-reconstructionTotal
Age, Customized
<=40 years
319 participants10 participants61 participants0 participants390 participants
Age, Customized
>=60 years
0 participants15 participants2 participants6 participants23 participants
Age, Customized
Between 40 and 60 years
136 participants73 participants84 participants9 participants302 participants
Sex: Female, Male
Female
455 Participants98 Participants147 Participants15 Participants715 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 4550 / 980 / 1470 / 15
serious
Total, serious adverse events
0 / 4550 / 980 / 1470 / 15

Outcome results

Primary

Local Complications

By patient risk of complications occuring in at least 5% of patients in 1 or more cohorts

Time frame: 10 years

Population: all enrolled patients

ArmMeasureGroupValue (NUMBER)
Primary AugmentationLocal ComplicationsSeroma/Fluid Accumulation1.8 percentage by patient
Primary AugmentationLocal ComplicationsWrinkling1.8 percentage by patient
Primary AugmentationLocal ComplicationsSkin Rash0.9 percentage by patient
Primary AugmentationLocal ComplicationsImplant Palpability/Visibility1.6 percentage by patient
Primary AugmentationLocal ComplicationsBreast Pain11.5 percentage by patient
Primary AugmentationLocal ComplicationsSwelling9.2 percentage by patient
Primary AugmentationLocal ComplicationsImplant Malposition6.9 percentage by patient
Primary AugmentationLocal ComplicationsBruising0.4 percentage by patient
Primary AugmentationLocal ComplicationsNipple Complications6.3 percentage by patient
Primary AugmentationLocal ComplicationsCapsular Contracture18.9 percentage by patient
Primary AugmentationLocal ComplicationsHypertrophic/Other Abnormal Scarring4.2 percentage by patient
Primary AugmentationLocal ComplicationsAsymmetry3.3 percentage by patient
Primary ReconstructionLocal ComplicationsNipple Complications3.3 percentage by patient
Primary ReconstructionLocal ComplicationsAsymmetry23.2 percentage by patient
Primary ReconstructionLocal ComplicationsSkin Rash2.0 percentage by patient
Primary ReconstructionLocal ComplicationsImplant Palpability/Visibility6.4 percentage by patient
Primary ReconstructionLocal ComplicationsSwelling7.1 percentage by patient
Primary ReconstructionLocal ComplicationsWrinkling10.2 percentage by patient
Primary ReconstructionLocal ComplicationsHypertrophic/Other Abnormal Scarring5.5 percentage by patient
Primary ReconstructionLocal ComplicationsSeroma/Fluid Accumulation2.3 percentage by patient
Primary ReconstructionLocal ComplicationsCapsular Contracture24.6 percentage by patient
Primary ReconstructionLocal ComplicationsBreast Pain6.8 percentage by patient
Primary ReconstructionLocal ComplicationsImplant Malposition2.3 percentage by patient
Primary ReconstructionLocal ComplicationsBruising1.0 percentage by patient
Revision-augmentationLocal ComplicationsCapsular Contracture28.7 percentage by patient
Revision-augmentationLocal ComplicationsImplant Malposition6.0 percentage by patient
Revision-augmentationLocal ComplicationsBreast Pain11.7 percentage by patient
Revision-augmentationLocal ComplicationsSwelling8.2 percentage by patient
Revision-augmentationLocal ComplicationsNipple Complications1.4 percentage by patient
Revision-augmentationLocal ComplicationsHypertrophic/Other Abnormal Scarring6.6 percentage by patient
Revision-augmentationLocal ComplicationsAsymmetry6.5 percentage by patient
Revision-augmentationLocal ComplicationsWrinkling5.4 percentage by patient
Revision-augmentationLocal ComplicationsImplant Palpability/Visibility6.0 percentage by patient
Revision-augmentationLocal ComplicationsSeroma/Fluid Accumulation6.0 percentage by patient
Revision-augmentationLocal ComplicationsBruising3.0 percentage by patient
Revision-augmentationLocal ComplicationsSkin Rash0.7 percentage by patient
Revision-reconstructionLocal ComplicationsHypertrophic/Other Abnormal Scarring0 percentage by patient
Revision-reconstructionLocal ComplicationsNipple Complications0 percentage by patient
Revision-reconstructionLocal ComplicationsSwelling0 percentage by patient
Revision-reconstructionLocal ComplicationsSeroma/Fluid Accumulation6.7 percentage by patient
Revision-reconstructionLocal ComplicationsImplant Malposition13.3 percentage by patient
Revision-reconstructionLocal ComplicationsBreast Pain0 percentage by patient
Revision-reconstructionLocal ComplicationsSkin Rash6.7 percentage by patient
Revision-reconstructionLocal ComplicationsBruising6.7 percentage by patient
Revision-reconstructionLocal ComplicationsWrinkling0 percentage by patient
Revision-reconstructionLocal ComplicationsAsymmetry6.7 percentage by patient
Revision-reconstructionLocal ComplicationsCapsular Contracture6.7 percentage by patient
Revision-reconstructionLocal ComplicationsImplant Palpability/Visibility6.7 percentage by patient
Secondary

Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale

Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied

Time frame: 10 years

Population: All patients who had a breast implant satisfaction rating

ArmMeasureGroupValue (MEAN)Dispersion
Primary AugmentationSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePhysician satisfaction4.8 units on a scaleStandard Deviation 0.7
Primary AugmentationSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePatient satisfaction4.8 units on a scaleStandard Deviation 0.7
Primary ReconstructionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePatient satisfaction4.6 units on a scaleStandard Deviation 0.7
Primary ReconstructionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePhysician satisfaction4.7 units on a scaleStandard Deviation 0.6
Revision-augmentationSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePhysician satisfaction4.4 units on a scaleStandard Deviation 1.1
Revision-augmentationSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePatient satisfaction4.4 units on a scaleStandard Deviation 1.2
Revision-reconstructionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePhysician satisfaction4.6 units on a scaleStandard Deviation 1.1
Revision-reconstructionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePatient satisfaction4.5 units on a scaleStandard Deviation 1.4

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026